Yang Hee Jo, Kim Ki Hong, Kim Doo Sang, Lee Chang Ho, Jeon Youn Soo, Shim Sung Ryul, Kim Jae Heon
Department of Urology, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.
Department of Health and Medical Informatics, Kyungnam University College of Health Sciences, Changwon, Korea.
World J Mens Health. 2023 Oct;41(4):861-873. doi: 10.5534/wjmh.220171. Epub 2023 Jan 4.
Healthy aging is an important concern in an aging society. Although the causal relationship between hypogonadism and erectile dysfunction in elderly men remains unclear, many physicians have achieved positive results after implementing exogenous testosterone supplementation therapy in patients with normal or slightly low blood testosterone. The purpose of this study was to conduct a systematic review and meta-analysis on whether testosterone replacement therapy (TRT) could improve sexual function in the elderly, as reported recently.
As a comprehensive literature search was performed to find articles published in PubMed, Embase, and Cochrane databases by January 2022. The search used keywords of 'aged', 'male', 'sexual behavior', and 'testosterone'. Randomized controlled trials (RCTs) were finally selected. As the main effect variable, results of a questionnaire on sexual function were analyzed and the effects of TRT were compared to those of placebo control.
Five RCT studies were included in this meta-analysis. The overall improvement by mean difference of sexual function for testosterone supplementation was 0.082 (95% CI: -0.049 to 0.213). In subgroup analysis, only intramuscular injection of 1,000 mg testosterone significantly improved sexual function of the elderly (0.229, 95% CI: 0.112 to 0.347). There was no significant difference in sexual function according to testosterone dose in meta-ANOVA (p=0.957). The difference was not statistically significant either in the meta-regression test (p=0.310). Egger's regression coefficient test did not indicate a publication bias (p=0.132).
Although our overall effect size (that is, sexual function effect of TRT) did not show a significant improvement, the direction of improvement in erection and motivation was clearly shown. The injection formulation resulted in a significant sexual function improvement. Since only a few RCTs were included in the analysis, more well-designed prospective studies are needed to have a definite conclusion.
在老龄化社会中,健康老龄化是一个重要关注点。尽管老年男性性腺功能减退与勃起功能障碍之间的因果关系仍不明确,但许多医生在对血液睾酮水平正常或略低的患者实施外源性睾酮补充治疗后取得了积极效果。本研究的目的是对近期报道的睾酮替代疗法(TRT)是否能改善老年人性功能进行系统评价和荟萃分析。
通过全面检索PubMed、Embase和Cochrane数据库,查找截至2022年1月发表的文章。检索使用了“老年人”“男性”“性行为”和“睾酮”等关键词。最终选择随机对照试验(RCT)。作为主要效应变量,分析性功能问卷结果,并将TRT的效果与安慰剂对照的效果进行比较。
本荟萃分析纳入了5项RCT研究。睾酮补充治疗后性功能平均差异的总体改善值为0.082(95%CI:-0.049至0.213)。在亚组分析中,仅肌肉注射1000mg睾酮能显著改善老年人的性功能(0.229,95%CI:0.112至0.347)。在meta方差分析中,根据睾酮剂量,性功能无显著差异(p = 0.957)。在meta回归检验中差异也无统计学意义(p = 0.310)。Egger回归系数检验未显示发表偏倚(p = 0.132)。
虽然我们的总体效应量(即TRT的性功能效应)未显示出显著改善,但勃起和性欲的改善方向清晰显示。注射剂型导致性功能显著改善。由于分析中仅纳入了少数RCT,需要更多设计良好的前瞻性研究才能得出明确结论。